“…As is well known, the activation of these pathways leads to increased levels of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8. Of note, these cytokines are key mediators of CS-induced lung inflammation as well [17,19,22,24,25,[27][28][29][30]32,33,36,37,40,42,[44][45][46][69][70][71]74,75,[77][78][79][80][81]83,90,98,99,102,104,112,113]. ROS, increased by CS, enhance the activation of the IκB kinase (IKK) complex (IKKβ, IKKα, and NF-κB essential modulator (NEMO), leading to the phosphorylation, ubiquitination and proteasomal degradation of IκB, in particular IκBα.…”